TOMI(TM) Environmental Solutions, Inc. Reports Second Quarter 2015 Financial Results

BEVERLY HILLS, Calif., Aug. 11, 2015 (GLOBE NEWSWIRE) -- TOMI™ Environmental Solutions, Inc. (OTCQB:TOMZ) (TOMI), a global bacteria decontamination and infection prevention company, reported its financial results for the three months ended June 30, 2015.

Dr. Halden Shane, TOMI's Chief Executive Officer, stated: "TOMI continues to build momentum for our products and execute our plan to address the large-scale opportunities in the infection control market, and the second quarter represented an important juncture in our evolution. We received registration from the Environmental Protection Agency (EPA) for our SteraMist™ Binary Ionization Technology® (BIT™) product, which is now an approved hospital product. With this registration in hand, we have begun ramping-up our efforts to escalate SteraMist adoption domestically and globally. In addition, we raised $8 million via a strategic investment which we used to retire our debt, increase working capital and significantly strengthen our foundation on which to grow."

"As we look ahead, we are very encouraged by our opportunities. Our SteraMist adoption strategy is supported by several initiatives:

  • First, we are expanding TOMI Service Network (TSN™), which provides our SteraMist products and training for large-event mobilization response. TSN rapid response infection prevention specialists will license and sell our SteraMist platform regionally, nationally and internationally.
  • Second, we continue to develop products that leverage our BIT to provide innovative solutions for the decontamination and disinfection of indoor air and surfaces.
  • Third, we are also maintaining prudent cost controls while also investing in our future, including improving manufacturing, hiring key personnel and expanding the TSN.
  • Lastly, we continue to invest in furthering our EPA, USDA and FDA claims to unlock even more opportunities for market growth."

Financial Results for the Three Months Ended June 30, 2015 Compared to 2014

  • Net revenue was $740,000, compared to $416,000.
  • Gross margins were 62.7%, compared to 66.8%. Loss from operations was $1.9 million, compared to $724,000.
  • During the three-month period ended June 30, 2015, the Company recorded several non-cash charges related to the retirement of its convertible notes:
    • Amortization of debt discounts of $3.0 million;
    • Fair value adjustment of derivative liability of $1.1 million;
    • Induced conversion loss of $930,000;
    • Interest expense of $127,000; and
    • Amortization of deferred financing costs of $115,000.
  • Net loss, including the aforementioned non-cash charges, was $7.2 million, or $0.08 per share, compared to net income of $416,000, or $0.00 per diluted share.
  • At June 30, 2015, cash and cash equivalents were $3.7 million and working capital was $4.5 million, an increase of $6.3 million over the $1.8 million working capital deficit reported at December 31, 2014.

Recent Business Highlights

  • Received EPA registration of TOMI's SteraMist™ with BIT™ as an approved hospital product on June 24th.
  • Raised $8 million via a strategic investment as announced on June 29th.
  • Expanded the TSN™ with 16 new members.
  • Launched providing significant educational and informational resources to the TSN members.

Conference Call Information

To listen to the call, please dial 1-888-339-0752 or 1-412-902-4193, passcode #10070901. To listen to the webcast or view the press release, please visit the Investor Relations section of the TOMI website at:

The replay can be accessed for up to 24 hours starting at 8:00 p.m. ET the day of the call by dialing 1-877-344-7529 or 1-412-317-0088, passcode # 10070901. A replay of the webcast will be available for at least 90 days on the company's website, starting approximately one hour after the completion of the call.

About TOMI Environmental Solutions, Inc.

TOMI Environmental Solutions, Inc. (OTCQB:TOMZ) is a global bacteria decontamination and infectious disease control company, providing eco-friendly environmental solutions for indoor surface decontamination through manufacturing, sales and licensing of our premier platform of Hydrogen Peroxide based products that uses Binary Ionization Technology® (BIT) , a state of the art technology for the production of its six-log mist represented by the TOMI™ SteraMist™ brand.

TOMI's products are designed to service a broad spectrum of commercial structures including hospitals and medical facilities, cruise ships, office buildings, hotel and motel rooms, schools, restaurants, for non-food safety in meat and produce processing facilities, military barracks, and athletic facilities. TOMI's products and services have also been used in single-family homes and multi-unit residences.

TOMI also develops training programs and application protocols for its clients and is a member in good standing with The American Biological Safety Association, The American Association of Tissue Banks, Association for Professionals in Infection Control and Epidemiology, Society for Healthcare Epidemiology of America, The Restoration Industry Association, Indoor Air Quality Association, and The International Ozone Association. For additional product information, visit or contact us at

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

Certain written and oral statements made by us may constitute "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Reform Act"). Forward-looking statements are identified by such words and phrases as "we expect," "expected to," "estimates," "estimated," "current outlook," "we look forward to," "would equate to," "projects," "projections," "projected to be," "anticipates," "anticipated," "we believe," "could be," and other similar phrases. All statements addressing operating performance, events, or developments that we expect or anticipate will occur in the future, including statements relating to revenue growth, earnings, earnings-per-share growth, or similar projections, are forward-looking statements within the meaning of the Reform Act. They are forward-looking, and they should be evaluated in light of important risk factors that could cause our actual results to differ materially from our anticipated results. The information provided in this document is based upon the facts and circumstances known at this time. We undertake no obligation to update these forward-looking statements after the date of this release.

For The Three Months Ended For The Six Months Ended
June 30, June 30,
2015 2014 2015 2014
Sales, net $739,934 $416,455 $1,416,320 $689,484
Cost of Sales 275,968 138,140 554,444 251,986
Gross profit 463,966 278,315 861,876 437,498
Operating Expenses:
Professional Fees 87,773 76,995 194,805 190,825
Depreciation and Amortization 123,957 112,388 249,210 224,294
Selling Expenses 97,091 115,707 191,826 177,155
Research and Development 19,667 65,851 41,857 97,142
Equity Compensation Expense 1,385,743 263,173 1,510,830 1,405,522
Consulting fees 338,233 25,750 414,542 84,153
General and Administrative 270,272 342,697 541,586 544,342
Total Operating Expenses 2,322,737 1,002,561 3,144,657 2,723,433
Loss from Operations (1,858,770) (724,246) (2,282,780) (2,285,935)
Other Income (Expense):
Amortization of Deferred Financing Costs (115,175) (85,388) (199,625) (169,838)
Amortization of Debt Discounts (3,032,685) (142,487) (3,996,033) (217,455)
Fair Value Adjustment of Derivative Liability (1,137,807) 1,494,832 (3,810,955) 3,246,137
Induced Conversion Costs (930,383) -- (930,383) --
Interest Expense (126,850) (126,850) (253,700) (254,256)
Total Other Income (Expense) (5,342,899) 1,140,107 (9,190,695) 2,604,588
Net Income (Loss) ($7,201,669) $415,861 ($11,473,475) $318,653
Net Income (Loss) Per Common Share
Basic ($0.08) $0.01 ($0.13) $0.00
Diluted ($0.08) $0.00 ($0.13) $0.00
Basic Weighted Average Common Shares Outstanding 87,767,261 80,225,890 85,828,777 80,186,585
Diluted Weighted Average Common Shares Outstanding 87,767,261 126,938,242 85,828,777 124,740,705
Current Assets: 30-Jun-15 31-Dec-14
Cash and Cash Equivalents $3,680,381 $160,560
Cash – Restricted (Note 6) -- 105,776
Accounts Receivable - net 823,309 441,153
Inventories (Note 3) 956,119 772,833
Prepaid Expenses 91,413 35,404
Other Assets 36,613 36,644
Deferred Financing Costs – net (Note 6) -- 199,625
Total Current Assets 5,587,835 1,751,995
Property and Equipment – net (Note 4) 243,390 288,159
Other Assets:
Intangible Assets – net (Note 5) 2,472,302 2,657,056
Security Deposits 4,700 6,552
Total Other Assets 2,477,002 2,663,608
Total Assets $8,308,227 $4,703,762
Current Liabilities:
Accounts Payable and Accrued Expenses $673,647 $448,063
Accrued Interest on Convertible Notes (Note 6) -- 211,417
Accrued Officers Compensation (Note 9) 54,000 41,000
Common Stock to be Issued (Note 12) 330,726 35,925
Customer Deposits 19,619 19,716
Deferred Rent 17,090 15,236
Derivative Liability (Note 7) -- 1,728,883
Convertible Notes Payable, net of discount at December 31, 2014 of $3,996,033 (Note 6) -- 1,077,967
Total Current Liabilities 1,095,082 3,578,207
Total Liabilities 1,095,082 3,578,207
Commitments and Contingencies -- --
Stockholders' Equity:
Cumulative Convertible Series A Preferred Stock; par value $0.01, 1,000,000 shares authorized; 510,000 shares issued and outstanding at June 30, 2015 and December 31, 2014 5,100 5,100
Cumulative Convertible Series B Preferred Stock; $1,000 stated value; 7.5% Cumulative dividend; 4,000 shares authorized; none issued and outstanding at June 30, 2015 and December 31, 2014 -- --
Common stock; par value $0.01, 200,000,000 shares authorized; 112,299,592 and 83,646,275 shares issued and outstanding at June 30, 2015 and December 31, 2014, respectively. 1,122,996 836,463
Additional Paid-In Capital 36,556,179 19,281,647
Accumulated Deficit (30,471,130) (18,997,655)
Total Stockholders' Equity 7,213,145 1,125,555
Total Liabilities and Stockholders' Equity $8,308,227 $4,703,762

CONTACT: INVESTOR RELATIONS CONTACT: Becky Herrick & Kirsten Chapman LHA (IR Agency) (415) 433-3777 MEDIA RELATIONS CONTACT: Aaron Loveland VP of Marketing and Public Affairs (240) 672-6263

Source:TOMI Environmental Solutions, Inc.